Alumni of UC Los Angeles (Graduate)
JeniVision located in Irvine California, is a biotech/pharmaceutical startup focused on next generation therapies for eye and skin diseases. Our pre-clinical product candidate, JV-DE1, is to be developed as the first prescription eye drop for directly treating and immediately reversing pain/irritation associated with dry eye disease, environmental pollution, injury, eye strain and surgery. It is a multi-billion dollar opportunity in dry eye pain/irritation alone. We are seeking $3 million series A funding for pre-clinical studies and FDA investigational new drug (IND) filing.
Primary Industry Sector: Medical Therapeutics
Funding Status: Seed